Teva Sues FDA Over Delisted Risperdal Patent
Generic-drug maker Teva Pharmaceuticals USA Inc. has filed suit against the U.S. Food and Drug Administration and two government officials seeking an injunction that would force the regulator to relist a...To view the full article, register now.
Already a subscriber? Click here to view full article